Rhabdomyosarcoma: all 242 studies
Page 3 of 3. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.
- Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue SarcomaCompletedNCT00876031Phase 3
- Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
- Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1
- Evaluating Dactinomycin and Vincristine in Young Patients With CancerCompletedNCT00674193
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 1
- Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer SyndromeCompletedNCT00565903
- Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
- HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
- Combination Chemotherapy in Treating Young Patients With Nonmetastatic RhabdomyosarcomaStatus unknownNCT00379457Phase 3
- EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in ChildrenStatus unknownNCT00339118Phase 4
- Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245141Phase 2
- Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245089Phase 2
- Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
- Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
- Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in RelapseStatus unknownNCT00180947Phase 2
- Rhabdomyosarcoma and Malignant Soft Tissue Tumours of ChildhoodTerminatedNCT00162695Phase 3
- ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00132158Phase 1
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk RhabdomyosarcomaActive, not recruitingNCT00077285Phase 2
- Exatecan Mesylate in Treating Children With Relapsed or Refractory RhabdomyosarcomaCompletedNCT00055939Phase 2
- Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsCompletedNCT00025441Phase 2
- Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaCompletedNCT00025363Phase 2
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
- Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the BoneCompletedNCT00006234Phase 1/2
- Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
- Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaCompletedNCT00003958Phase 3
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaCompletedNCT00003955Phase 2
- Health-Related Outcomes in Patients Who Were Previously Treated for RhabdomyosarcomaCompletedNCT00003801Not applicable
- Genetic Study of Children With Soft Tissue Sarcoma or RhabdomyosarcomaCompletedNCT00003793
- S9624 Ifosfamide in Treating Patients With Meningeal TumorsTerminatedNCT00003292Phase 2
- Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or RhabdomyosarcomaCompletedNCT00003081Phase 1
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaCompletedNCT00002995Phase 3
- Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue SarcomaCompletedNCT00002898Phase 3
- Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid TumorsCompletedNCT00002543Phase 1
- Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare DiseasesCompletedNCT00001686
- A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric SarcomasCompletedNCT00001564Phase 2
- New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and NeuroblastomaCompletedNCT00001335Phase 2